S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

VRXA

Veraxa Biotech AG - Post de-SPAC
NASDAQ
1.76
+0.23 +15.03%
USD · close Sep 4

One year, everything drawn on

251 SESSIONS · DAILY CLOSES
27188.54-0.53Aug 27 · Director buy $75KAug 27 · Chief Executive Officer buy $8KSEP 2025OCTJAN 2026APRJUL
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-09-06
Insiders (90d): $83K net buying · 2 distinct buyers
Shorts (latest report): 378K short · −21K last period
Every line of the math
64WATCH

Congress is trading it

No STOCK Act disclosure names VRXA.

Insider activity

ALL 2
DateInsiderTypeValue
Aug 27DirectorBuy$75K
Aug 27Chief Executive OfficerBuy$8K
Watch VRXA. Know when insiders buy.
One email the day a filing lands. Free.